1. Home
  2. OLMA vs EAF Comparison

OLMA vs EAF Comparison

Compare OLMA & EAF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OLMA
  • EAF
  • Stock Information
  • Founded
  • OLMA 2006
  • EAF 1886
  • Country
  • OLMA United States
  • EAF United States
  • Employees
  • OLMA 88
  • EAF N/A
  • Industry
  • OLMA Biotechnology: Pharmaceutical Preparations
  • EAF Industrial Machinery/Components
  • Sector
  • OLMA Health Care
  • EAF Energy
  • Exchange
  • OLMA Nasdaq
  • EAF Nasdaq
  • Market Cap
  • OLMA 465.4M
  • EAF 514.3M
  • IPO Year
  • OLMA 2020
  • EAF 1995
  • Fundamental
  • Price
  • OLMA $5.92
  • EAF $1.91
  • Analyst Decision
  • OLMA Strong Buy
  • EAF Hold
  • Analyst Count
  • OLMA 5
  • EAF 6
  • Target Price
  • OLMA $26.25
  • EAF $1.80
  • AVG Volume (30 Days)
  • OLMA 1.0M
  • EAF 1.7M
  • Earning Date
  • OLMA 11-12-2024
  • EAF 11-12-2024
  • Dividend Yield
  • OLMA N/A
  • EAF N/A
  • EPS Growth
  • OLMA N/A
  • EAF N/A
  • EPS
  • OLMA N/A
  • EAF N/A
  • Revenue
  • OLMA N/A
  • EAF $541,710,000.00
  • Revenue This Year
  • OLMA N/A
  • EAF N/A
  • Revenue Next Year
  • OLMA N/A
  • EAF $4.97
  • P/E Ratio
  • OLMA N/A
  • EAF N/A
  • Revenue Growth
  • OLMA N/A
  • EAF N/A
  • 52 Week Low
  • OLMA $6.10
  • EAF $0.52
  • 52 Week High
  • OLMA $16.78
  • EAF $2.53
  • Technical
  • Relative Strength Index (RSI)
  • OLMA 23.84
  • EAF 46.15
  • Support Level
  • OLMA $6.25
  • EAF $1.82
  • Resistance Level
  • OLMA $6.87
  • EAF $2.12
  • Average True Range (ATR)
  • OLMA 0.82
  • EAF 0.19
  • MACD
  • OLMA -0.34
  • EAF -0.03
  • Stochastic Oscillator
  • OLMA 0.00
  • EAF 25.00

About OLMA Olema Pharmaceuticals Inc.

Olema Pharmaceuticals inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of next generation targeted therapies for women's cancers. Its therapies offer the potential to improve outcomes for women living with cancer. The company has completed discovery and preclinical studies of OP-1250. OP-3136 is another drug candidate in the company's product pipeline.

About EAF GrafTech International Ltd.

GrafTech International Ltd is a manufacturer of high-quality graphite electrode products essential to the production of EAF steel and other ferrous and non-ferrous metals. The company has only reportable segment, Industrial Materials, is comprised of its two major product categories: graphite electrodes and petroleum needle coke products. Petroleum needle coke is key raw material used in the production of graphite electrodes.

Share on Social Networks: